IP Library Granted Patent US 9,677,073
Granted Patent B2
US 9,677,073 · App. 14/432,327 · Granted Jun 13, 2017

Hydroxylated polyamine derivatives as transfection reagents

Inventors: Steffen Panzner (Halle, DE); Christian Reinsch (Halle, DE); Volkmar Wendisch (Dessau, DE); Christina Dreher (Halle, DE)
C12N15/113A61K47/48046A61K47/48192A61K47/48315C08G73/0206C08L79/02C12N15/85C08L2203/02C12N2310/14C12N2310/351C12N2800/107
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,677,073
App. No.
14/432,327
Granted
Jun 13, 2017
Kind
B2
Abstract

The invention provides hydroxylated polyamine derivatives, their use for the transfection of polyanions into cells, and a method of transfecting cells with a polyanion, comprising mixing said polyanion with said hydroxylated polyamine derivative in a buffer and treating said cells with the mixture obtained in the previous step.

Claims (4)

1. A polyalkylenimine derivative having one or more hydroxyalkyl substituents comprising from 4 to 40 carbon atoms, and one or more hydrophobic substituents selected from hydrocarbon substituents having at least 2 carbon atoms, wherein each of said hydrophobic substituents may be or may comprise an alkyl group and/or each of said hydrophobic substituents may be or may comprise an aryl group.

2. An hydroxyalkyl-alkyl-polyamine derivative according to claim 1 , wherein said hydroxyalkyl-alkyl-polyamine has one type of said hydroxyalkyl moiety and one type of said alkyl moiety, and the sum of carbon atoms in the type of hydroxyalkyl moiety and the type of alkyl moiety is between 10 and 30.

3. The polyalkylenimine derivative of claim 1 wherein said one or more hydrophobic substituents selected from hydrocarbon substituents having at least 6 to 40 carbon atoms.

4. The polyalkylenimine derivative according to claim 2 , wherein said sum of carbon atoms of the hydroxyalkyl and alkyl moieties is between 15 and 25.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2020
From: PANZNER, STEFFEN; REINSCH, CHRISTIAN; WENDISCH, VOLKMAR; DREHER, CHRISTINA
To: LIPOCALYX GMBH
Reel/Frame 053864/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2020
From: LIPOCALYX GMBH
To: BIONTECH PROTEIN THERAPEUTICS GMBH
Reel/Frame 053866/0348 →
CHANGE OF NAME Recorded Sep 23, 2020
From: BIONTECH PROTEIN THERAPEUTICS GMBH
To: BIONTECH DELIVERY TECHNOLOGIES GMBH
Reel/Frame 053866/0352 →
Priority Claims (1)
EP 12006913 · Oct 5, 2012 · regional
Continuity (1)
Related Publication 20150259678A1 · Sep 17, 2015